Tecovirimat - SIGA Technologies
Alternative Names: Arestvyr; SIGA-246; ST-246 Form I (monohydrate); ST-246 Form V (hemihydrate); ST-246®; Tecovirimat - SIGA Technologies; Tecovirimat monohydrate - SIGA Technologies; TPOXXLatest Information Update: 21 Aug 2024
At a glance
- Originator ViroPharma
- Developer National Institute of Allergy and Infectious Diseases; SIGA Technologies
- Class Antivirals; Benzamides; Cyclopropanes; Fluorinated hydrocarbons; Isoindoles; Organic bridged compounds; Small molecules
- Mechanism of Action Orthopoxvirus p37 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Smallpox
- Registered Monkeypox; Orthopoxvirus infections; Vaccinia